Cardiac Health Assessment
A comprehensive cardiovascular and preventive health evaluation includes advanced biomarkers and imaging studies that offer deeper insights into inflammation, lipid risk, and cardiac function. Key blood tests include high-sensitivity C-reactive protein (hs-CRP) to assess vascular inflammation, Apolipoprotein B (ApoB) to determine atherogenic particle burden, Lipoprotein(a) [Lp(a)] for genetic LDL-related risk, and an NMR Lipoprotein Profile to evaluate particle number and size.
Key Features

Cardiac Health Assessment
-
High-sensitivity C-Reactive Protein (hs-CRP) – marker of vascular inflammation.
-
Apolipoprotein B (ApoB) – atherogenic particle number.
-
Lipoprotein(a) [Lp(a)] – genetic LDL variant, one-time measurement.
-
NMR Lipoprotein Profile – particle count & size.
-
NT-proBNP (or BNP) – marker of heart failure/stress.

Imaging & Functional Assessments
-
Echocardiogram – structure, ejection fraction, valve disease.
-
Carotid Ultrasound / Doppler – atherosclerosis burden.
-
Coronary CT Calcium Score – coronary artery calcification (40–70 yrs, intermediate risk).
-
Cardiac CT Angiography – for higher-risk groups or persistent symptoms.
-
Exercise Stress Test – treadmill/bike with ECG monitoring.

Advanced / Optional Add-Ons
-
PSA (prostate), CA-125 (ovarian), CEA, AFP, CA 19-9,
-
Cardiac MRI – fibrosis, cardiomyopathy, myocarditis.
-
Genetic Panels for Cardiovascular Risk (e.g., FH, arrhythmia genes).
-
Wearable Monitoring – arrhythmia detection (patch, Holter, or smart device integration).